Clinical Trial

Exparel Injection Effect on Postoperative Opioid Usage

Unknown Early Phase 1
View on ClinicalTrials.gov →
Summary
The question proposed by this study, is one of patient outcomes. Does intraoperative injection of Exparel decrease postoperative use of opioid pain medications in patients undergoing thyroid and parathyroid surgery? The trial seeks to assess the effect that Exparel has on postoperative pain control.
Protocol Amendment History 1 change
critical Trial status changed: Enrolling by Invitation → Unknown 2026-08-02
Trial Details
NCT Number NCT04085913
Lead Sponsor University of Missouri-Columbia
Conditions Thyroid, Parathyroid Adenoma
Enrollment 100 participants
Start Date 2019-09-30
Primary Completion 2024-06-06 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2024-07-29